Male Urinary Incontinence Market (2025 - 2033) Size, Share & Trends Analysis Report By Product, By Incontinence Type (Stress Urinary Incontinence, Urge Urinary Incontinence), By Usage, By Distribution Channel, By End-use, By Region, And Segment Forecasts

Male Urinary Incontinence Market Summary

The global male urinary incontinence market size was estimated at USD 7.10 billion in 2024 and is projected to reach USD 11.92 billion by 2033, growing at a CAGR of 5.97% from 2025 to 2033. This growth is attributed to the aging population, rising incidence of prostate-related surgeries, and increasing awareness about incontinence management.

Advancements in medical technology, including male slings, artificial urinary sphincters, and magnetic stimulation devices, are improving patient outcomes and driving adoption. The growing number of clinical trials across regions further underscores innovation in treatment approaches, expanding the therapeutic pipeline. According to the Canadian Cancer Society, in 2024, prostate cancer remains a significant health concern among Canadian men, with approximately 27,900 new diagnoses, accounting for 22% of all newly diagnosed cancer cases in men.

Prostate cancer is a major driver of the male urinary incontinence industry’s growth, mainly due to the high incidence of urinary complications that arise following its treatment. Prostate cancer treatments, particularly radical prostatectomy (surgical removal of the prostate gland), radiotherapy, and hormone therapy, can lead to significant damage or weakening of the pelvic floor muscles, sphincter mechanism, and bladder function. This results in stress urinary incontinence, urge incontinence, or mixed forms of incontinence. Post-prostatectomy incontinence is one of the most common complications, affecting a substantial proportion of men in the months and even years following surgery. Similarly, radiation therapy can cause bladder irritation, reduced storage capacity, and involuntary leakage. As survival rates improve and more men live longer after prostate cancer treatment, the prevalence of urinary incontinence also rises, creating sustained demand for effective management options.

“Prostate cancer is one of the most common cancers in men, with ‘one in six men affected during their lifetime’: As per the Indian Council of Medical Research, around 47,000 new cases are diagnosed annually in India, accounting for 3 percent of all cancer cases. This number is expected to rise over the next 10 to 20 years due to increasing life expectancy and improved access to affordable healthcare.”- Dr. Rama Krishna, consultant in radiation oncology at Manipal Hospitals

Growing clinical trials drive the male urinary incontinence market by accelerating product development, improving treatment efficacy, and building trust among healthcare professionals and patients. As more trials are conducted, they validate the safety and effectiveness of novel devices such as male slings, artificial urinary sphincters, neuromodulation systems, and regenerative therapies. These studies help generate real-world evidence, which supports faster regulatory approvals and wider clinical adoption. In addition, the participation of major sponsors and academic institutions enhances the credibility of emerging technologies, encouraging investment and innovation.

Some clinical trials for urinary incontinence:

Source: ClinicalTrials.gov

Neurodegenerative disorders such as Alzheimer’s disease (AD) and Parkinson’s disease (PD) are key contributors to the rising prevalence of male urinary incontinence, particularly among older adults. Both conditions affect the brain regions responsible for controlling bladder function, leading to urgency, frequency, nocturia, and involuntary leakage. In Alzheimer’s patients, cognitive decline results in the inability to recognize the need to void or to locate a restroom in time, which leads to functional incontinence. In Parkinson’s disease, motor symptoms such as bradykinesia and rigidity impair the patient’s ability to reach the toilet quickly, while autonomic dysfunction contributes to detrusor overactivity, resulting in urge incontinence. As the global population ages and the incidence of these neurological disorders rises, the number of men affected by incontinence secondary to such conditions continues to increase.

The below table shows how various neurological and neurodegenerative disorders contribute to the development of urinary incontinence in men.

• According to the Alzheimer's Association 2025, an estimated 7.2 million Americans aged 65 and older are projected to be living with Alzheimer’s dementia in 2025.

  • 74% of those affected are aged 75 or older.

  • Among the total U.S. population: Approximately 1 in 9 people (11%) aged 65 and older have Alzheimer’s dementia.

  • 33.4% of people aged 85 and older are affected.

• According to the Parkinson's Foundation, an estimated 1.1 million people in the U.S. are currently living with Parkinson's disease, a number projected to rise to 1.2 million by 2030.

Neurological conditions and their impact on male urinary incontinence:

Source: Alzheimer’s Association, 2025

Market Concentration & Characteristics

The male urinary incontinence market is in a medium-growth stage, characterized by expansion driven by rising awareness, increasing geriatric population, and the gradual adoption of advanced management solutions. Key contributors to this medium-growth phase include the growing prevalence of chronic conditions like prostate disorders, diabetes, and neurological diseases, which are major risk factors for incontinence.

The male urinary incontinence market is witnessing significant innovation driven by advances in medical technology, regenerative medicine, and patient-centric device development. A notable degree of innovation is evident through the development of next-generation artificial urinary sphincters, such as the UroMems device, which integrates innovative technology for improved continence control.

The market has witnessed moderate to growing merger and acquisition (M&A) activity in recent years, primarily driven by strategic goals such as portfolio expansion, market entry, and technological innovation. One notable trend is the consolidation of innovative startups and small-scale medical device manufacturers with proprietary technologies. This is evident in acquisitions targeting advanced sling systems, artificial urinary sphincters, and novel bioengineered therapies. For instance, in January 2024, Boston Scientific acquired Axonics to expand its urology portfolio by adding differentiated technologies for treating urinary and bowel dysfunction. Axonics, known for its innovative sacral neuromodulation and incontinence solutions, strengthens Boston Scientific’s position in the urology market by adding minimally invasive, long-term treatment options for overactive bladder and fecal incontinence.

Regulations significantly impact developing, approving, and commercializing devices and therapies in the male urinary incontinence market. Stringent regulatory frameworks, especially in the U.S. (FDA), Europe (CE marking under MDR), and Japan (PMDA), ensure the safety, efficacy, and quality of urinary incontinence products, including slings, and artificial urinary sphincters.

Product expansion in the male urinary incontinence industry is gaining momentum as manufacturers diversify their portfolios to cater to a broader spectrum of patient needs and clinical scenarios. Companies are expanding beyond traditional artificial urinary sphincters by introducing adjustable sling systems, external collection devices, and implantable stimulators. These products offer varying invasiveness, efficacy, and user control levels, thus enabling more personalized treatment plans.

Regional expansion is playing a crucial role in driving the market growth, with key players actively extending their footprint beyond established markets in North America and Europe. Companies are increasingly targeting emerging economies in Asia-Pacific, Latin America, the Middle East & and Africa, driven by rising awareness, improving healthcare infrastructure, and increasing aging male populations. For instance, clinical trials and pilot studies are now being conducted in countries such as Turkey, India, Belarus, and China, indicating a growing interest in adapting advanced therapies for broader regional use. Manufacturers collaborate strategically with regional hospitals, research institutions, and distributors to facilitate local market entry, navigate regulatory pathways, and enhance service delivery.

Product Insights

Absorbents held the largest market share in 2024. This dominance is attributed to their widespread availability, ease of use, and cost-effectiveness. Absorbents, such as adult diapers, pads, and guards, are the first line of management for mild to moderate incontinence and are commonly used in clinical settings and at home. Their non-invasive nature makes them a preferred choice among older adults, especially those with mobility issues or cognitive impairments. In addition, continuous product innovation, such as improved absorbency, odor control, and skin-friendly materials, has significantly boosted consumer confidence and adoption rates. The increasing demand from the aging population, along with the growing focus on maintaining patient dignity and quality of life, has further fueled the growth of this segment. Moreover, strong distribution networks through pharmacies, supermarkets, and e-commerce platforms have made absorbents more accessible to a broader population, strengthening their market leadership.

The non-absorbents segment is expected to grow at a significant CAGR during the forecast period, driven by the increasing adoption of advanced urinary incontinence management devices such as external catheters, penile clamps, drainage bags, and male external urine collection systems. These products offer a more discreet and long-term solution for patients seeking greater comfort and mobility. The rising prevalence of chronic conditions such as prostate enlargement, neurological disorders, and post-surgical incontinence has led to increased demand for non-absorbent solutions, particularly among the elderly male population. Technological advancements in device design-such as skin-friendly materials, improved fit, and reduced risk of leakage-also enhance product acceptance. Moreover, growing awareness about hygiene, infection prevention, and the availability of home care solutions are encouraging patients to shift toward these alternatives. Supportive reimbursement policies and clinical recommendations for long-term management are expected to further boost the growth of the non-absorbents segment in the forecast years.

Incontinence Type Insights

The urge urinary incontinence segment held the largest market share of around 56.81% in 2024. This dominance is primarily due to the high prevalence of overactive bladder among aging men, which is often associated with conditions such as benign prostatic hyperplasia, diabetes, and neurological disorders like Parkinson’s disease or stroke. Urge incontinence is characterized by a sudden, intense urge to urinate, followed by involuntary leakage, making it a significant concern for quality of life. The increasing awareness and diagnosis rates of UUI, along with a broader range of treatment options-including medications, behavioral therapies, electrical stimulation, and surgical interventions-are contributing to the segment’s leading position. As per reports published by the National Library of Medicine in August 2023, 423 million individuals worldwide suffer from urine incontinence. Urinary incontinence affects 13 million American citizens on average. Tenants of nursing facilities face a prevalence of at least 50% for this condition.

The mixed urinary incontinence (MUI) segment is projected to grow at the fastest CAGR during the forecast period, driven by the increasing incidence of patients exhibiting stress and urge incontinence symptoms. MUI is particularly prevalent among the elderly male population, especially those with comorbid conditions such as prostate disorders, obesity, and neurological impairments. The complexity of managing dual symptoms has heightened the demand for comprehensive and multimodal treatment approaches, including a combination of behavioral therapy, pelvic floor exercises, pharmacological agents, and advanced medical devices. Growing clinical awareness, improved diagnostic capabilities, and the development of personalized treatment plans are further fueling the segment’s growth.

Usage Insights

The disposable segment held the largest share of the male urinary incontinence industry in 2024. This dominance is primarily attributed to the convenience, hygiene, and cost-effectiveness that disposable products offer patients and caregivers. Products such as disposable adult diapers, pads, liners, and male guards are widely used for their ease of use and ability to minimize the risk of infections and skin irritation. The growing elderly population, particularly those with limited mobility or cognitive impairments, has significantly contributed to the demand for disposable solutions in home care and institutional settings. In addition, product innovations-such as ultra-absorbent cores, odor control technologies, and ergonomic designs-have improved comfort and user satisfaction, further driving adoption. Expanding retail and e-commerce distribution channels has also made these products more accessible to end users. As awareness of incontinence management increases globally, the disposable segment is expected to maintain its leading position in the forecast years.

The reusable segment is expected to grow at a significant CAGR during the forecast period, driven by increasing consumer preference for sustainable and cost-effective incontinence management solutions. Reusable products such as washable adult briefs, cloth-based pads, and incontinence underwear are gaining traction, particularly among environmentally conscious consumers and long-term care users. These products offer durability and reduce long-term costs compared to disposables, making them attractive for individual users and institutional settings. Moreover, advancements in fabric technology, such as moisture-wicking, odor control, and skin-friendly materials, have enhanced the comfort and efficacy of reusable incontinence products. As global concerns around medical waste and environmental sustainability intensify, healthcare providers and consumers are turning to reusable alternatives. Growing awareness, improved product availability through online platforms, and government-led sustainability initiatives are further expected to drive the segment growth.

Distribution Channel Insights

The offline stores segment held the largest market share in 2024, due to the long-established presence and wide availability of physical stores across the globe. Numerous consumers prefer shopping through offline distribution channels as it provides them with product verification, authenticity, and certainty. Moreover, offline stores offer convenience, customization options, and personalized assistance, which are expected to drive the growth of this segment. Through the offline mode, customers do not have to wait for shipping to complete their purchases. The sales staff might offer suggestions and guidance based on the needs of the consumer. Customers can physically inspect products to make sure they satisfy their needs. The stores that offer medical supplies, including urinary incontinence products, may be attached or located next to medical facilities such as hospitals and clinics. Patients and their carers may find this arrangement to be highly convenient.

The online channel segment is expected to grow at the fastest CAGR during the forecast period. The growth is expected to be driven by the wide product selection and attractive discounts that are available online. In addition, chatbots and FAQ pages assist customers in addressing their queries related to product search, prescriptions, and overall user experience, thereby enhancing the online shopping experience. People may browse and buy things while resting at home via online shopping. People with mobility challenges or those who feel uncomfortable making such purchases in person benefit from this buying mode. Some online merchants provide subscription services, which let customers receive their chosen products on a regular basis without having to place additional orders. Manufacturers and retailers in the urinary incontinence sector can build their online presence by working with well-known e-commerce platforms or by developing their own websites. To reach and inform their target audience, they also use digital marketing tactics which ultimately boost industry growth.

End-use Insights

Hospitals & clinics held the largest revenue share of 71.19% in 2024. This significant share is primarily attributed to the high patient inflow in these settings for diagnosis, treatment, and postoperative care of urinary incontinence. Hospitals offer access to advanced diagnostic equipment, surgical interventions, and multidisciplinary teams, which ensure comprehensive care for patients suffering from varying degrees of incontinence. Moreover, skilled urologists and healthcare professionals contribute to better management outcomes, thereby driving patient preference toward hospital-based treatments. The increasing adoption of advanced urinary catheters, external urine management devices, and other assistive technologies in hospital environments further supports this trend. In addition, rising awareness campaigns conducted by hospitals and clinics and improved reimbursement policies in many countries have further enhanced access to care, supporting the segment’s dominant position in the market.

The homecare segment is expected to grow at the fastest CAGR during the forecast period. Home care plays an important role in the management of incontinence in men. Homecare for male incontinence focuses on maintaining hygiene, utilizing absorbent products, managing fluids, exercising the pelvic floor muscles, adopting a healthy lifestyle, making environmental modifications, and seeking appropriate medical assistance when needed. It also promotes comfort, confidence, and overall well-being for individuals managing incontinence at home.

Recent innovations in the male urinary incontinence market, particularly in home care and absorbent products, are propelled by digital sensing technology and comfort-focused designs. For instance, in July 2024, Mexple’s recent launch of UroMen and UroWomen urine collection kits marks a significant step in advancing the home care segment for male urinary incontinence. These kits, designed for home settings and long-term care, offer a discreet, hygienic, and reusable solution for managing incontinence. The products contain medical-grade materials, anti-backflow valves, and comfortable silicone cavities, which minimize skin contact with urine, helping reduce infection risks, odor, and discomfort.

Regional Insights

North America male urinary incontinence market is expected to witness the fastest CAGR in the global industry during the forecast period. This growth is primarily driven by the region's aging population, particularly in countries such as the U.S. and Canada, where a significant proportion of the male population is entering age groups more susceptible to urinary incontinence. In addition, the increasing prevalence of chronic health conditions such as diabetes, obesity, and neurological disorders-key contributors to bladder dysfunction-is fueling the demand for incontinence products and services. As of 2024, an estimated 56.2 million adults aged 20-79 in the North America and Caribbean (NAC) region are living with diabetes. This number is projected to rise further to 68.1 million by 2050, highlighting the increasing burden of diabetes in the region and its potential implications for associated health conditions such as urinary incontinence.

The region also benefits from high healthcare expenditure, advanced medical infrastructure, and strong reimbursement policies, which support the widespread availability and adoption of innovative and high-quality incontinence solutions. Moreover, growing awareness about men's urinary health, the reduction of social stigma around incontinence, and active educational campaigns have led to improved diagnosis and treatment-seeking behavior. Technological advancements, including wearable and discreet incontinence devices, further enhance user convenience and compliance, contributing to market growth.

U.S. Male Urinary Incontinence Market Trends

The male urinary incontinence industry in the U.S. is experiencing growth, driven by rising chronic disease prevalence and advancements in healthcare. A key factor is the rapidly aging male population, as age-related bladder dysfunction and prostate-related conditions, such as benign prostatic hyperplasia and prostate cancer, become common. The high prevalence of chronic diseases such as diabetes, obesity, and neurological disorders, including Parkinson’s disease and stroke, further contributes to the growing number of men affected by urinary incontinence. According to the Vintage 2024 Population Estimates released by the U.S. Census Bureau, the population aged 65 and older in the U.S. increased by 3.1%, reaching 61.2 million, while the population under age 18 declined by 0.2%, totaling 73.1 million between 2023 and 2024.

Europe Male Urinary Incontinence Market Trends

Europe male urinary incontinence market dominated with the largest revenue share of 48.88% in 2024. This growth is attributed to demographic, clinical, and economic factors. The region’s large and rapidly aging male population is a key driver, as age-related conditions such as benign prostatic hyperplasia, prostate cancer, and neurological disorders significantly increase the risk of urinary incontinence. On 1 January 2024, 449 million people lived in the European Union (EU), representing a 0.4% increase from the 448 million recorded on 1 January 2023. The most populous EU countries were:

• Germany (83.4 million, 19% of the EU total)

• France (68.4 million, 15%)

• Italy (58.9 million, 13%)

• Spain (48.6 million, 11%)

Furthermore, Europe’s well-developed healthcare infrastructure ensures timely diagnosis and access to a wide range of treatment options, from absorbent products and external catheters to surgical interventions. The presence of leading market players actively engaged in product innovation has resulted in more advanced, comfortable, and discreet incontinence management solutions specifically designed for men.

Key players are adopting strategic initiatives, such as partnerships and new launches, along with a focus on sustainability, which are poised to propel market growth. For instance, in January 2022, Attindas Hygiene Partners introduced its environment-friendly adult incontinence protective underwear in Europe, aimed at reducing carbon emissions. The company also implemented a new product design that utilizes ultrasonic bonding instead of traditional glue adhesive, resulting in a significant reduction in greenhouse gas emissions, particularly carbon dioxide. This innovation aligns with Attindas' commitment to reducing its environmental footprint.

The male urinary incontinence market in the UK is expected to grow significantly in the forecast period. Driven by the country’s aging male population, as older men are more susceptible to incontinence due to age-related physiological changes, prostate enlargement, and post-surgical complications such as those following prostatectomy. Additionally, the high prevalence of chronic conditions like diabetes, obesity, and neurological disorders such as Parkinson’s disease and multiple sclerosis contributes significantly to bladder dysfunction in men.

As per Cancer Research UK:

• Prostate cancer mortality rates in the UK are projected to fall by 5% between 2023 and 2025 and 2038-2040.

• Despite the decline in mortality rate, there could be around 17,500 prostate cancer deaths annually by 2038-2040.

• Incidence rates of prostate cancer are projected to rise by 15% during the same period.

• By 2038-2040, there could be approximately 85,100 new prostate cancer cases each year in the UK.

In August 2024, BOG STANDARD is a public awareness campaign in the UK designed to tackle the stigma surrounding male urinary incontinence and encourage men to seek support and treatment. Spearheaded by a coalition of healthcare organizations, charities, and patient advocacy groups, the campaign aims to normalize conversations around incontinence. This condition affects thousands of men across the country, especially those over 50 or with prostate-related issues.

Through bold messaging, educational materials, and real-life testimonials, "BOG STANDARD" highlights that incontinence is more common than many think-and that managing it is not a sign of weakness, but of taking control. The campaign offers practical guidance on treatment options, lifestyle tips, and access to support networks, including links to NHS resources and continence clinics. "BOG STANDARD" also partners with urologists, general practitioners, and pharmacists to help men feel more comfortable discussing their symptoms and accessing care. By breaking down barriers of embarrassment, the campaign empowers men to act earlier, improving quality of life and reducing the long-term impact of untreated urinary incontinence.

“phs Group is a business that puts people at the heart of its products and services, and the BOG STANDARD Charter builds on the joint initiative we proudly launched with Prostate Cancer UK last year. Our aim is to remove the stigma around male incontinence and work with our customers to provide facilities for men to dispose of their incontinence facilities with dignity. It’s what we would want for our friends, colleagues, family members or ourselves, and this is why we are so passionate about this cause.” - Matthew Brabin, phs Group’s CEO

The Germany male urinary incontinence market is growing, primarily driven by the country’s aging male population, which is among the oldest in Europe. As age-related bladder dysfunction and chronic health conditions become more common, the demand for incontinence management solutions continues to rise. In addition, the high prevalence of prostate disorders, including benign prostatic hyperplasia, prostate cancer, and complications following prostate surgery, significantly contributes to the growing number of male incontinence cases.

Germany’s advanced healthcare infrastructure and supportive reimbursement policies by statutory health insurers ensure broad access to diagnostics, treatments, and quality incontinence products. The market also benefits from technological advancements, such as developing discreet, comfortable, and skin-friendly products that improve patient compliance and daily life. Furthermore, increased public awareness, reduced stigma, and the rising burden of chronic conditions such as diabetes, obesity, and neurological disorders are prompting more men to seek timely medical support. As of 2024, an estimated 6.5 million adults aged 20-79 in Germany are living with diabetes, reflecting a significant increase from previous years and highlighting the growing burden of the disease in the country.

Asia Pacific Male Urinary Incontinence Market Trends

The male urinary incontinence industry in Asia Pacific is witnessing significant growth. A rapidly aging population-particularly in countries such as China, Japan, and India-is significantly increasing the prevalence of age-related bladder dysfunction and prostate-related conditions, both major contributors to male incontinence. Rising awareness about urinary health, fueled by educational campaigns and reduced social stigma, encourages more men to seek diagnosis and adopt management solutions. Technological advancements have led to the development of discreet, comfortable, and absorbent products such as pads, guards, and external catheters, which are gaining popularity due to their convenience and effectiveness. Moreover, the growth of online retail channels and home care services is improving product accessibility, especially in urban areas. Economic development and rising healthcare expenditures in emerging markets like India and China further support the adoption of incontinence products.

The India male urinary incontinence market is growing,driven by demographic changes, increasing disease burden, and improving healthcare access. With a rapidly aging population and a rising incidence of prostate-related conditions such as benign prostatic hyperplasia, more men are encountering bladder control issues that require medical management. Health awareness campaigns, changing social attitudes, and a gradual reduction in stigma are encouraging more men to acknowledge and seek treatment for incontinence. This condition has long been underreported in India. Expanding online retail platforms and healthcare infrastructure in Tier-II and Tier-III cities is improving accessibility to quality incontinence products. Moreover, government initiatives such as Ayushman Bharat and the expansion of insurance coverage are beginning to support incontinence-related care, further propelling market growth.

For instance, in February 2024,Anil Baghi Hospital in Firozpur, Punjab, launched an awareness campaign to educate the public about common urinary problems in older adults. The campaign focuses on six prevalent issues: kidney stones, bladder cancer, urinary retention, interstitial cystitis, urinary incontinence, and urinary tract infections (UTIs). The hospital hopes to reduce stigma and promote proactive healthcare-seeking behavior among older adults by dispelling myths and encouraging open conversations.

“Urinary problems are unfortunately quite common among older adults and can significantly impact their quality of life. Through this campaign, we aim to raise awareness about these conditions, dispel myths, and encourage individuals to seek timely medical attention when needed.” - Dr. Saurabh Baghi, CEO & Cardiologist at Anil Baghi Hospital

The male urinary incontinence market in China is expected to experience significant growth during the forecast period. This growth is supported by expanding access to healthcare services, increased government focus on elder care, and growing public awareness of urinary incontinence as a manageable medical condition rather than a taboo subject. Multinational and domestic manufacturers focus on product innovation, comfort, and discretion, while distribution partnerships and digital retail enhance product accessibility across urban and semi-urban regions. As China continues to invest in healthcare infrastructure and reduce stigma around male urinary health, the market is expected to experience growth over the coming years. With a rapidly aging population and increasing life expectancy, the prevalence of age-related urinary conditions among Chinese men is rising. As per the WHO, the population of people over 60 in China is projected to reach 28% by 2040.

Middle East and Africa Male Urinary Incontinence Market Trends

Growth of the male urinary incontinence industry in the Middle East and Africa (MEA) is driven by the increasing geriatric population, particularly in countries such as South Africa and the UAE, where improvements in life expectancy are resulting in a higher prevalence of age-related conditions such as urinary incontinence. In addition, the rising burden of chronic diseases-including diabetes, obesity, prostate disorders, and neurological conditions is significantly contributing to the growing incidence of urinary incontinence among men. These health issues lead to weakened bladder control and associated complications, thereby increasing the demand for incontinence management solutions.

Another critical factor is the gradual improvement in healthcare infrastructure and access to urological care, especially in urban centers across the GCC and Sub-Saharan Africa. Governments and private healthcare providers are increasingly investing in diagnostic services and urology departments, which facilitates early detection and treatment of incontinence.

Key Male Urinary Incontinence Company Insights

Key market players are focusing on the launch of innovative medical devices, growth strategies, and technological advancements, as well as regulatory approvals for treatments associated with urinary incontinence. For instance, in August 2023, the U.S. Food and Drug Administration approved a De Novo commercialization application for the Revi System, a revolutionary tibial neuromodulation treatment for the management of urgent urinary symptoms on their own or in conjunction with urgency incontinence.

Recent Developments

• In April 2025, Ontex completed the divestment of its Brazilian operations to Softys. This transaction marks a strategic step in Ontex’s ongoing portfolio optimization efforts, allowing the company to focus on its core markets and strengthen its overall operational efficiency.

• In February 2025, First Quality Enterprises, LLC (“First Quality”) signed a definitive agreement to acquire Henkel’s Retailer Brands business in North America. As part of the transaction, First Quality will establish a new division, First Quality Home Care Products, which will function as an independent business unit within the First Quality Group.

• In April 2024, Medline has expanded its catheter offerings by signing an exclusive agreement to distribute the QiVi MEC male external urine management device, developed by Consure Medical, across acute‑care settings in North America

Male Urinary Incontinence Market Report Scope

Global Male Urinary Incontinence Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global male urinary incontinence market report based on product, incontinence type, usage, distribution channel, end-use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Non-Absorbents

    • Urinary Catheters

      • Foley Catheters

      • External Catheters

    • Drainage Bags

    • External Compression Devices/Penile Clamps

    • Artificial Urinary Sphincter

    • Others

  • Absorbents

    • Underwear & Briefs

    • Drip Collectors & Bed Protectors

    • Pads & Guards

• Incontinence Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Stress Urinary Incontinence

  • Urge Urinary Incontinence

  • Overflow Incontinence

  • Functional Urinary Incontinence

  • Mixed Urinary Incontinence

• Usage Outlook (Revenue, USD Million, 2021 - 2033)

  • Reusable

  • Disposable

• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)

  • Offline Stores

  • Online Channels

• End-use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals & Clinics

  • Homecare

  • Others

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Norway

    • Denmark

    • Sweden

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait